Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 27, 2026
Can you apply?
This grant is for researchers who have completed or are completing NIH career development awards (K01, K08, K23, K25) or equivalent awards from NIAMS partner organizations. Applicants must be in their second to fourth year of their K award when applying.
The grant supports pilot studies, feasibility studies, secondary data analysis, small research projects, methodology development, and new research technology. Clinical trials of any phase are not allowed.
This is a limited competition with a fixed deadline. The R03 mechanism is designed to bridge the gap between career development support and independent research funding like R01 grants.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- May 5, 2025 Applications open
- Oct 20, 2025 Application deadline
- Jul 1, 2026 Award announced
- Jul 1, 2026 Project start
Program description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for a program that provides NIAMS-supported K01, K08, K23, and K25 recipients and recipients of career development awards from organizations that support research in NIAMS’ mission areas the opportunity to apply for Small Grant (R03) support at an appropriate point during the second to fourth year of their K award. This is a limited competition. Through the use of this mechanism, the NIAMS is seeking to enhance the capability of its scientists to conduct research as they complete their transition to fully independent investigator status. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R03 activity code. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support research projects that can be carried out in a short period of time with limited resources and that provide support, in addition to the career development award, for a subsequent R01, or equivalent, application. Clinical trials of any phase will not be supported by this NOFO. Eligible investigators are encouraged to begin to consider applying for this new NOFO.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- NIH R03 NOFO instructions (when published)
- Biographical sketch
- Project narrative
- Budget and budget justification
- Institutional support letter
- Vertebrate animals or human subjects documentation (if applicable)
Program contact
- 👤 Su-Yau Mao, Ph.D.
- 📧 su-yau.mao@nih.gov
- 📞 301-451-1945
Funding track record
Recent awards under CFDA 93.846 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$63,962,483
-
$60,038,896
-
$34,166,872
-
$27,648,731
-
$24,598,295
-
$21,654,386
-
$20,225,012
-
$16,326,540
-
$15,274,546
-
$14,828,008
Top States by Funding
- CA 13 awards $124.1M
- MA 15 awards $123.0M
- NY 12 awards $107.4M
- NC 4 awards $102.5M
- PA 11 awards $101.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.846). How funding has trended year over year.
| 2018 | $476,478,975 | |
| 2019 | $490,084,446 | |
| 2020 | $505,547,334 | |
| 2021 | $509,241,630 | |
| 2022 | $499,786,367 | |
| 2023 | $548,439,000 | |
| 2024 est. | $545,593,000 | |
| 2025 est. | $541,712,000 |
FAQ
Who is eligible to apply?
You must be a current K01, K08, K23, or K25 recipient, or hold an equivalent career development award from a NIAMS partner organization. You must be in years 2-4 of your K award.
Are clinical trials allowed?
No, clinical trials of any phase are not supported by this program.
What types of projects are funded?
Pilot studies, feasibility studies, secondary data analysis, methodology development, and new research technology development are supported.
What is the relationship to other NIH grants?
This R03 is designed to provide additional funding during your career development award, preparing you for a subsequent R01 or equivalent independent research grant.
When is the deadline?
The deadline is October 20, 2025. This is a fixed deadline, not a rolling acceptance.
💡 Tips for applicants
- Ensure you are in years 2-4 of your K award when you apply; applications outside this window will be ineligible.
- Frame your project as a logical stepping stone toward future R01-level independent research.
- Consider projects that can be completed with limited resources and time, not large-scale studies.
- Avoid any clinical trial components; pilot studies must not involve human subjects testing of interventions.
- Start building collaborations and finalizing your project concept immediately, given the fixed October deadline.
⚠️ Common mistakes
Applying too early or late in your K award (not in years 2-4). Including any clinical trial activity, even pilot phase trials. Proposing projects too large or complex for R03 scope and limited resources.
Similar grants
- OPEN Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) — National Institutes of Health
- OPEN Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) — National Institutes of Health
- OPEN Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) — National Institutes of Health
- OPEN Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) — National Institutes of Health
- OPEN Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) — National Institutes of Health